Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
532.6 INR | -1.34% | -3.94% | +8.87% |
Jun. 18 | Aarti Drugs Reports Fire Incident at Tarapur, India Unit | MT |
May. 06 | Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024 |
Chart calendar Aarti Drugs Limited
Upcoming events on Aarti Drugs Limited
Past events on Aarti Drugs Limited
2024-05-29 12:30 am | B&K Securities Trinity Investor Conference |
2024-05-06 01:30 am | Q4 2024 Earnings Call |
2024-05-03 07:07 am | Q4 2024 Earnings Release |
2024-03-28 01:30 am | Arihant Capital Bharat Connect Conference |
2024-02-05 | Détachement de for dividende intermédiaire |
2024-01-25 01:30 am | Q3 2024 Earnings Call |
2024-01-24 05:32 am | Q3 2024 Earnings Release |
2023-11-07 11:30 pm | Anand Rathi Flagship G-200 Conference |
2023-10-20 01:30 am | Q2 2024 Earnings Call |
2023-10-19 06:30 am | Q2 2024 Earnings Release |
2023-09-26 01:00 am | Annual General Meeting |
2023-09-25 05:00 am | Investor Meeting |
2023-09-21 05:30 am | Investor Meeting |
2023-09-06 05:30 am | Investor Meeting |
2023-07-24 01:30 am | Q1 2024 Earnings Call |
2023-07-21 09:56 am | Q1 2024 Earnings Release |
2023-06-15 | Investor Meeting |
2023-05-02 12:30 am | Q4 2023 Earnings Call |
2023-04-29 11:06 am | Q4 2023 Earnings Release |
2023-02-27 | Investor Meeting - Goldman Sachs (India) Securities Pvt. Ltd |
Past dividends on Aarti Drugs Limited
2024-02-05 | Interim Payment 1 INR |
2023-02-07 | Interim Payment 1 INR |
2022-02-08 | Interim Payment 1 INR |
2020-11-02 | Interim Payment 2.5 INR |
2020-02-16 | Interim Payment 2 INR |
2019-07-25 | Annual 1 INR |
2018-07-31 | Annual 1 INR |
2017-08-08 | Annual 1 INR |
2016-03-21 | Interim Payment 3 INR |
2016-02-11 | Interim Payment 1.5 INR |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 15 609 14 522 7.49% | 18 061 18 338 -1.51% | 21 548 21 965 -1.9% | 24 887 24 552 1.36% | 27 161 26 590 2.15% | 25 286 26 118 -3.19% |
EBITDA Million INR | Released Forecast Spread | 2 074 2 043 1.51% | 2 618 2 444 7.13% | 4 371 4 670 -6.4% | 3 294 3 478 -5.28% | 3 056 3 027 0.97% | 3 165 3 186 -0.67% |
EBIT Million INR | Released Forecast Spread | 1 648 1 629 1.17% | 0,00 0,00 - | 3 872 4 179 -7.34% | 2 794 2 978 -6.18% | 2 553 2 438 4.71% | 2 650 2 583 2.6% |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 1 310 1 227 6.75% | 1 853 1 709 8.39% | 3 690 3 954 -6.67% | 2 700 2 877 -6.17% | 2 242 2 168 3.42% | 2 355 2 306 2.14% |
Net income Million INR | Released Forecast Spread | 898 824 8.88% | 1 414 1 141 23.97% | 2 804 2 977 -5.79% | 2 050 2 170 -5.51% | 1 663 1 633 1.84% | 1 714 1 730 -0.91% |
EPS INR | Released Forecast Spread | 9,62 8,77 9.73% | 15,1 12,2 23.76% | 30,1 32,0 -5.82% | 22,1 23,3 -5.06% | 18,0 17,6 1.91% | 18,6 18,7 -0.75% |
Announcement Date | 15/05/19 | 15/05/20 | 15/05/21 | 09/05/22 | 29/04/23 | 03/05/24 |
Quarterly results
Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 5 018 5 251 -4.44% | 5 800 6 270 -7.5% | 5 796 6 035 -3.96% | 6 348 5 939 6.89% | 6 943 6 076 14.26% | 6 220 7 029 -11.51% | 6 877 6 374 7.9% | 6 640 7 300 -9.05% | 7 424 7 082 4.83% | 6 611 7 011 -5.7% |
EBITDA Million INR | Released Forecast Spread | 809 1 002 -19.23% | 797 1 317 -39.47% | 737 969 -23.9% | 900 837 7.53% | 860 820 4.88% | 671 917 -26.79% | 743 761 -2.4% | |||
Net income Million INR | Released Forecast Spread | 517 621 -16.83% | 488 928 -47.4% | 426 559 -23.83% | 553 488 13.4% | 348 546 -36.28% | 388 388 -0.13% | ||||
Announcement Date | 15/05/21 | 27/07/21 | 27/10/21 | 31/01/22 | 09/05/22 | 27/07/22 | 20/10/22 | 27/01/23 | 29/04/23 | 21/07/23 |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Aarti Drugs Limited
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AARTIDRUGS Stock
- AARTIDRUGS Stock
- Calendar Aarti Drugs Limited